相关实验视频

Updated: May 10, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

最小残留疾病监测将成为常规监测的一部分吗?

Kerstin Pfister¹, Henning Schäffler¹, Sophia Huesmann¹

¹Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.

Oncology research and treatment

|February 25, 2025

概括

循环瘤DNA (ctDNA) 显示出早期乳腺癌 (BC) 复发检测的前景,为治疗提供了潜在的新窗口. 虽然ctDNA是一种可靠的预后生物标志物,但需要更多的研究来证实ctDNA引导监测对生存的好处.

科学领域:

在瘤学瘤学.
生物标志物发现发现
临床试验临床试验

背景情况:

目前的乳腺癌 (BC) 监测依赖于过时的检测复发的方法.
现有的监测协议不包括液体活检技术的进步,例如循环瘤DNA (ctDNA).

研究的目的:

评估ctDNA作为预后生物标志物在乳腺癌早期监测中的作用.
探索ctDNA引导的随访的潜力,以改善患者的治疗结果.
评估通过检测最小或分子残留疾病 (MRD) 提供的治疗窗口.

主要方法:

使用基于瘤的和瘤不可知的方法来检测ctDNA.
在预测临床乳腺癌复发时分析ctDNA的敏感性和特异性.
评估ctDNA检测和明显复发之间的领先时间.

主要成果:

ctDNA检测准确地预测了临床乳腺癌复发.
在ctDNA检测和临床复发之间的领先时间表明MRD的阶段.
ctDNA显示出早期治疗和缓解治疗的潜力.

结论:

ctDNA是早期乳腺癌监测的可靠预后生物标志物.
基于ctDNA的监测和辅助疗法有可能改善患者的治疗结果.
需要进行进一步的临床试验,以确定生存益处,并确认ctDNA引导的随访作为新的护理标准.

关键词:

乳腺癌是什么? 乳腺癌是什么循环瘤DNA是循环中的瘤DNA.液体活检是一种液体活检.监督监督监督监督监督监督监督监督监督监督监督监督

更多相关视频

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

相关概念视频

Principles of Disease Surveillance

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...